Stop smoking drug not linked to heart attacks or depression
Previous reports have linked varenicline to heart attacks, depression, self-harm and suicideRelated items from OnMedicaCombining varenicline with nicotine patch boosts quit ratesMetabolism impacts on success of nicotine replacement therapy Smoking cessationNRT can be prescribed to smokers who want to cut downSmoking cessation drugs not linked to suicide (Source: OnMedica Latest News)
Source: OnMedica Latest News - September 9, 2015 Category: UK Health Source Type: news

Medical News Today: Smoking cessation drug 'does not raise risk of heart disease, depression'
Contrary to previous reports, a new study suggests the widely used smoking cessation drug varenicline (Chantix) is not associated with heart disease, depression or self-harm. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 8, 2015 Category: Consumer Health News Tags: Smoking / Quit Smoking Source Type: news

Stop-smoking pill Champix 'does NOT raise the risk of heart attack or suicide'
The controversial drug Champix, known generically as varenicline, should be more widely prescribed in light of the findings, say University of Edinburgh and Dusseldorf researchers. (Source: the Mail online | Health)
Source: the Mail online | Health - September 8, 2015 Category: Consumer Health News Source Type: news

Popular stop-smoking pill 'does NOT raise the risk of heart attack or suicide'
The controversial drug Champix, known generically as varenicline, should be more widely prescribed in light of the findings, say University of Edinburgh and Dusseldorf researchers. (Source: the Mail online | Health)
Source: the Mail online | Health - September 7, 2015 Category: Consumer Health News Source Type: news

Quit-smoking drug not linked to heart disease or depression
A highly effective drug that helps smokers to quit does not increase their risk of heart attack and depression as was previously thought, research suggests. Researchers who carried out the study say doctors can prescribe varenicline - also known as Champix™ or ChantixTM - more widely to help people stop smoking. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - September 7, 2015 Category: Science Source Type: news

Pfizer's quit-smoking drug not linked to depression or heart risks
LONDON (Reuters) - Pfizer's stop-smoking drug Chantix does not raise risks of heart attack or depression, contrary to previous reports, and should be recommended to more smokers wanting to quit, scientists said on Monday. (Source: Reuters: Health)
Source: Reuters: Health - September 6, 2015 Category: Consumer Health News Tags: healthNews Source Type: news

Use of NHS stop smoking services falls by 23% in a year
Action needed to reverse downward trend, say experts Related items from OnMedicaCombining varenicline with nicotine patch boosts quit ratesSmoking cessationShopping vouchers boost quit rates in pregnant smokersCall for smoking to be banned in UK parksE-cigarettes 95% less harmful than tobacco (Source: OnMedica Latest News)
Source: OnMedica Latest News - August 20, 2015 Category: UK Health Source Type: news

Smoking cessation drug not boosting number of smokers who quit
The introduction of a new prescription smoking-cessation aid, varenicline, in 2006 has had no significant impact on the rate at which Americans age 18 and older successfully quit smoking, according to a study. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - August 17, 2015 Category: Science Source Type: news

Smoking cessation drug not boosting number of smokers who quit
(University of California - San Diego) The introduction of a new prescription smoking-cessation aid, varenicline, in 2006 has had no significant impact on the rate at which Americans age 18 and older successfully quit smoking, according to a study led by researchers at University of California, San Diego School of Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 17, 2015 Category: Global & Universal Source Type: news

No Suicide, Psychosis Risk With Varenicline?No Suicide, Psychosis Risk With Varenicline?
A large Swedish study links varenicline to new-onset anxiety and depression but not suicidal behavior, criminal acts, or traffic accidents, but at least one expert remains unconvinced. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 5, 2015 Category: Consumer Health News Tags: Psychiatry News Source Type: news

Chantix Study Finds Little Evidence to Support Suicidal, Criminal Warnings
But quit-smoking drug may be linked to other adverse effects Source: HealthDay Related MedlinePlus Pages: Drug Safety, Medicines, Quitting Smoking (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - June 3, 2015 Category: Consumer Health News Source Type: news

Chantix Study Finds Little Evidence to Support Suicidal, Criminal Warnings
Title: Chantix Study Finds Little Evidence to Support Suicidal, Criminal WarningsCategory: Health NewsCreated: 6/2/2015 12:00:00 AMLast Editorial Review: 6/3/2015 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - June 3, 2015 Category: Respiratory Medicine Source Type: news

No evidence that smoking drug linked to increased risk of suicide or traffic accidents
There is no strong evidence that the popular smoking cessation drug varenicline is associated with increased risks of suicidal behaviors, criminal offending, transport accidents, traffic-related offenses, and psychoses, finds a study. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 3, 2015 Category: Science Source Type: news

Entrepreneur Touts Cheap, Safe Smoking Cessation Drug -- But Is It?
Thus, is this product going to live up to its promise of a safer alternative to current treatments like Chantix and buproprion? Perhaps - but that still needs to be proven. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 18, 2015 Category: Pharmaceuticals Authors: John LaMattina Source Type: news

Extended Varenicline in a Severely Cardiopathic SmokerExtended Varenicline in a Severely Cardiopathic Smoker
Varenicline has been associated with an increased risk of cardiovascular adverse events in high-risk patients, but this case demonstrates that it can be safely used long-term with careful monitoring. Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 10, 2015 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news

Mind-destroying drug Chantix to receive new black box warning label
(NaturalNews) In response to a request from drug giant Pfizer to remove the "black box" warning on the smoking-cessation drug Chantix, the FDA has decided to not only retain the warning but expand it.A black box warning is the most severe action the FDA can take against a drug... (Source: NaturalNews.com)
Source: NaturalNews.com - April 7, 2015 Category: Consumer Health News Source Type: news

No Suicide Risk With Varenicline?No Suicide Risk With Varenicline?
A comprehensive meta-analysis shows no evidence of neuropsychiatric effects of varenicline, but the study has its detractors. Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - March 23, 2015 Category: Psychiatry Tags: Psychiatry News Source Type: news

Largest review of clinical trials to assess risk of patients using Varenicline
Findings from the largest review of clinical trials to date to determine whether patients prescribed the smoking cessation drug Varenicline (brand name Champix in the UK) are at an increased risk of neuropsychiatric events are have been published. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 12, 2015 Category: Science Source Type: news

Largest review of clinical trials to date finds no increased risk of suicide in patients using Champix
Findings from the largest review of clinical trials to date to determine whether patients prescribed the smoking cessation drug Varenicline (brand name Champix in the UK) are at an increased risk of neuropsychiatric events are published online in the British Medical Journal [BMJ] today [12 Mar]. The study was carried out by researchers at the University of Bristol. (Source: University of Bristol news)
Source: University of Bristol news - March 12, 2015 Category: Universities & Medical Training Tags: International, Research; Faculty of Medicine and Dentistry, School of Social and Community Medicine, Institutes, Elizabeth Blackwell; Press Release Source Type: news

News in Brief: Week of March 9-13
This roundup includes the following news briefs: FDA: Use Caution Mixing Chantix, Alcohol; VA Accelerates Deployment of Nationwide Opioid Therapy Tool; FDA Backs WHO Recommendations for 2015-16 Flu Vaccine Composition; Join HHS Network, Help Move Health Care Toward Value-based Payments; and Harvard Medical School Announces Inaugural InciteHealth Fellows. (Source: AAFP News)
Source: AAFP News - March 12, 2015 Category: Primary Care Source Type: news

Largest review of clinical trials to assess risk of patients using Champix
(University of Bristol) Findings from the largest review of clinical trials to date to determine whether patients prescribed the smoking cessation drug Varenicline (brand name Champix in the UK) are at an increased risk of neuropsychiatric events are published online in the British Medical Journal today. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 12, 2015 Category: Global & Universal Source Type: news

FDA Warns of Seizure, Alcohol Risk With Chantix
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - March 11, 2015 Category: Journals (General) Source Type: news

FDA Warns of Seizure, Alcohol Risk With Chantix
Title: FDA Warns of Seizure, Alcohol Risk With ChantixCategory: Health NewsCreated: 3/11/2015 12:00:00 AMLast Editorial Review: 3/11/2015 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - March 11, 2015 Category: Respiratory Medicine Source Type: news

New FDA warning for anti-smoking drug Chantix
Drug already comes with a warning of suicidal or violent behavior, and now there's something else to be wary of (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - March 11, 2015 Category: Consumer Health News Source Type: news

FDA: Chantix Carries Potential Alcohol Interaction and Seizure Risk (FREE)
By Kristin J. Kelley Edited by Lorenzo Di Francesco, MD, FACP, FHM The FDA has approved a label change to varenicline (Chantix) to warn that the smoking cessation drug could "change the way people react to alcohol." Additionally, the label … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - March 11, 2015 Category: Primary Care Source Type: news

Quitting smoking? FDA flags alcohol, seizure risks for Chantix users
The U.S. Food and Drug Administration is warning smokers who are trying to quit that they may have trouble tolerating alcohol if they are taking Chantix. (Source: Los Angeles Times - Science)
Source: Los Angeles Times - Science - March 10, 2015 Category: Science Source Type: news

FDA Warns of Seizure, Alcohol Risk With Chantix
The FDA has changed the labeling on the quit-smoking drug Chantix to reflect concerns that it may lower your tolerance to alcohol and is linked to a rare risk of seizures. (Source: WebMD Health)
Source: WebMD Health - March 10, 2015 Category: Consumer Health News Source Type: news

Morning Break: No Reprieve for Chantix; Rx Spending Spike
(MedPage Today) -- Health news and commentary from around the Web, gathered by the MedPage Today staff. (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - March 10, 2015 Category: American Health Source Type: news

U.S. FDA warns of seizure, alcohol risk with Pfizer's Chantix
(Reuters) - The U.S. Food and Drug Administration warned on Monday that Pfizer Inc's quit-smoking drug, Chantix, has been associated with seizures and that some patients who drink while taking the drug may become aggressive or black out. (Source: Reuters: Health)
Source: Reuters: Health - March 9, 2015 Category: Consumer Health News Tags: healthNews Source Type: news

Chantix (varenicline): Drug Safety Communication - FDA Updates Label to Include Potential Alcohol Interaction
Rare risk of seizures, and studies of side effects on mood, behavior, or thinking. Posted 03/09/2015 (Source: FDA MedWatch)
Source: FDA MedWatch - March 9, 2015 Category: American Health Source Type: news

Chantix May Lower Alcohol Tolerance, Up Seizure Risk: FDAChantix May Lower Alcohol Tolerance, Up Seizure Risk: FDA
The FDA has changed the labeling on the smoking cessation medication Chantix to reflect concerns that the drug may lower alcohol tolerance and boost seizure risk. News Alerts (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 9, 2015 Category: Consumer Health News Tags: Psychiatry News Source Type: news

Stop-Smoking Drug Helps HIV Patients Kick Habit (CME/CE)
(MedPage Today) -- But success rates with varenicline were still low. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - March 1, 2015 Category: Cardiology Source Type: news

Cardiac Regeneration/Stop-Smoking Drug/Juicing: Mayo Clinic Radio
On this week’s Mayo Clinic Radio: fixing a broken heart. Cardiac regeneration uses the body’s own stem cells to repair damage done by heart disease, Mayo Clinic cardiologist Dr. Atta Behfar explains. Also, Mayo Clinic registered dietitian Katherine Zeratsky explains the risks of juice-only diets. Plus, nicotine dependency expert Dr. Richard Hurt joins the program to discuss results of a new study about the stop-smoking drug varenicline (Chantix). Click here [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - February 23, 2015 Category: Databases & Libraries Source Type: news

Mayo clinic radio
On this week’s Mayo Clinic Radio: fixing a broken heart. Cardiac regeneration uses the body’s own stem cells to repair damage done by heart disease, Mayo Clinic cardiologist Dr. Atta Behfar explains. Also, Mayo Clinic registered dietitian Katherine Zeratsky explains the risks of juice-only diets. Plus, nicotine dependency expert Dr. Richard Hurt joins the program to discuss results of a new study about the stop-smoking drug varenicline (Chantix).  Myth or [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - February 20, 2015 Category: Databases & Libraries Source Type: news

Drug may help people gradually quit smoking
Anti-smoking drug Chantix can help smokers cut back, but "its success comes with a cost" -- serious side effects (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - February 18, 2015 Category: Consumer Health News Source Type: news

Chantix Linked to Higher Quit Rates in Certain Smokers: Study
Title: Chantix Linked to Higher Quit Rates in Certain Smokers: StudyCategory: Health NewsCreated: 2/17/2015 12:00:00 AMLast Editorial Review: 2/18/2015 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - February 18, 2015 Category: Respiratory Medicine Source Type: news

Varenicline May Be an Option for Smokers Who Aren't Willing to Quit Just Yet (FREE)
By Kelly Young Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM Varenicline (Chantix) leads to higher smoking cessation rates among smokers who say they're not quite ready to quit, according to an industry-funded study in … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - February 18, 2015 Category: Primary Care Source Type: news

Chantix Linked to Higher Quit Rates in Certain Smokers: Study
But drug's side effects still worry some doctors (Source: WebMD Health)
Source: WebMD Health - February 17, 2015 Category: Consumer Health News Source Type: news

Chantix Linked to Higher Quit Rates in Certain Smokers
But drug's side effects still worry some doctors Source: HealthDay Related MedlinePlus Pages: Medicines, Quitting Smoking (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - February 17, 2015 Category: Consumer Health News Source Type: news

Medicine Given Even Before Smokers Are Ready to Quit Is Found to Help Them
A study has found that even for people who are not ready to stop smoking immediately, medicine taken over time can improve their chances of eventually quitting. (Source: NYT Health)
Source: NYT Health - February 17, 2015 Category: Consumer Health News Authors: By SABRINA TAVERNISE Tags: Nicotine Chantix Smoking and Tobacco Medicine and Health Pfizer Inc Source Type: news

Medication Therapy Can Increase Long-Term Success For Smokers Who Cut Back First
https://www.youtube.com/watch?v=1Dg5bncTJsg ROCHESTER, Minn. — A study of more than 1,500 cigarette smokers who were not ready to quit smoking but were willing to cut back on cigarette consumption and combine their approach with varenicline (Chantix) increased their long-term success of quitting smoking. The multinational study is published in the February issue of the Journal of [...] (Source: Mayo Clinic Rochester News)
Source: Mayo Clinic Rochester News - February 17, 2015 Category: Hospital Management Source Type: news

Mayo Clinic Radio: Cardiac Regeneration/Stop-Smoking Drug/Juicing
On this week’s Mayo Clinic Radio, fixing a broken heart. Cardiac regeneration uses the body’s own stem cells to repair damage done by heart disease. Mayo Clinic cardiologist Dr. Atta Behfar explains. Also on the program, nicotine dependency expert Dr. Richard Hurt discusses results of a new study about the stop-smoking drug varenicline (Chantix). And Mayo [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - February 16, 2015 Category: Databases & Libraries Source Type: news

Varenicline as a cause of suicidal outcomes - Hughes JR.
This article reviews post-marketing analyses, case reports, clinical trials, uncontrolled observational studies, controlled observational studies, ... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - January 23, 2015 Category: Global & Universal Tags: Alcohol and Other Drugs Source Type: news

Blood test may tell you the 'best' way to quit smoking
Conclusion This is a well-conducted randomised controlled trial, which found that use of the nicotine-metabolite ratio (NMR) may be helpful in indicating which stop smoking treatment may be best for different people. For those with a normal NMR, varenicline was more effective than a nicotine patch. For slower metabolisers, there was no significant difference in the effectiveness of the two treatments, but they tended to get more side effects with varenicline. The study benefits from its large size, double-blind design and high follow-up rates. However, there are still questions to be answered. For example, the difference ...
Source: NHS News Feed - January 12, 2015 Category: Consumer Health News Tags: Heart/lungs Medication Medical practice Cancer Source Type: news

Varenicline May Affect Normal and Slow Metabolizers of Nicotine Differently (FREE)
By Kelly Young Edited by Susan Sadoughi, MD, and André Sofair, MD, MPH Varenicline is associated with higher cessation rates in smokers who metabolize nicotine normally but with more side effects in slow metabolizers, according to a Lancet … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - January 12, 2015 Category: Primary Care Source Type: news

Nicotine metabolism rates may impact success of smoking cessation treatments
A randomized clinical trial of smokers trying to quit found that the effectiveness of particular smoking cessation therapies might relate to how quickly their body metabolizes nicotine. The study compared success rates of the nicotine patch versus the prescription medication varenicline. Among... (Source: NIDA News)
Source: NIDA News - January 12, 2015 Category: Addiction Tags: Health and Medical Professionals, Researchers, Tobacco, Treatment Research Source Type: news

Nicotine metabolism rates may impact success of smoking cessation treatments
A randomized clinical trial of smokers trying to quit found that the effectiveness of particular smoking cessation therapies might relate to how quickly their body metabolizes nicotine. The study compared success rates of the nicotine patch versus the prescription medication varenicline. Among... (Source: NIDA News)
Source: NIDA News - January 12, 2015 Category: Addiction Tags: Health and Medical Professionals, Researchers, Tobacco, Treatment Research Source Type: news

Increasing Varenicline Dose Unlikely to Help in NonrespondersIncreasing Varenicline Dose Unlikely to Help in Nonresponders
Don't bother raising the dose of varenicline (Chantix) when smokers don't respond to the standard dose; it won't help, according to a new study. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 30, 2014 Category: Consumer Health News Tags: Psychiatry News Source Type: news

Varenicline Linked to Reduction in Heavy Drinking in Men
Also associated with smoking abstinence in overall sample of participants (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - November 11, 2014 Category: Psychiatry Tags: Family Medicine, Geriatrics, Internal Medicine, Nursing, Pharmacy, Psychiatry, Pulmonology, Journal, Source Type: news

Smoking Cessation Drug Tied to Increased Cardiovascular Risk
Varenicline associated with increased incidence of CV events in first 12 weeks after receipt of drug (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - November 11, 2014 Category: Psychiatry Tags: Cardiology, Family Medicine, Gynecology, Internal Medicine, Neurology, Nursing, Pharmacy, Psychiatry, Pulmonology, Journal, Source Type: news